DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAA) Net income
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.9MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAA financial trends
DMAA RevenueDMAA Net marginDMAA Gross profitDMAA Gross marginDMAA Operating incomeDMAA Operating marginDMAA Operating cash flowDMAA Free cash flowDMAA Capital expendituresDMAA Return on equityDMAA Stock buybacksDMAA Dividends paidDMAA Total assetsDMAA Total liabilitiesDMAA Shareholders’ equityDMAA overview →